[
  {
    "title": "Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue?",
    "published": 1742571029,
    "posting_price": 162.94000244,
    "close_price": 167.27999878,
    "percent_change": 2.66355485
  },
  {
    "title": "Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers",
    "published": 1742547790,
    "posting_price": 162.94000244,
    "close_price": 167.27999878,
    "percent_change": 2.66355485
  },
  {
    "title": "Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings",
    "published": 1740753306,
    "posting_price": 164.63999939,
    "close_price": 165.30999756,
    "percent_change": 0.40694738
  },
  {
    "title": "SGH and Charles River team up for CGMP cell banking services",
    "published": 1740501039,
    "posting_price": 170.63999939,
    "close_price": 167.1000061,
    "percent_change": -2.07453897
  },
  {
    "title": "Charles River Announces Agreement with Singapore General Hospital",
    "published": 1740488400,
    "posting_price": 170.63999939,
    "close_price": 167.1000061,
    "percent_change": -2.07453897
  },
  {
    "title": "Deciphering Charles River (CRL) International Revenue Trends",
    "published": 1740406510,
    "posting_price": 166.41000366,
    "close_price": 170.50999451,
    "percent_change": 2.46378869
  },
  {
    "title": "UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings",
    "published": 1740402225,
    "posting_price": 166.41000366,
    "close_price": 170.50999451,
    "percent_change": 2.46378869
  },
  {
    "title": "CRL Stock Up on Q4 Earnings and Revenue Beat, Margins Fall",
    "published": 1739991060,
    "posting_price": 159.27999878,
    "close_price": 165.0,
    "percent_change": 3.59116101
  },
  {
    "title": "Compared to Estimates, Charles River (CRL) Q4 Earnings: A Look at Key Metrics",
    "published": 1739975423,
    "posting_price": 159.27999878,
    "close_price": 165.0,
    "percent_change": 3.59116101
  },
  {
    "title": "Charles River beats quarterly estimates on stable demand for drug development services",
    "published": 1739970680,
    "posting_price": 159.27999878,
    "close_price": 165.0,
    "percent_change": 3.59116101
  },
  {
    "title": "Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call",
    "published": 1713176024,
    "posting_price": 244.32000732,
    "close_price": 235.92999268,
    "percent_change": -3.43402685
  },
  {
    "title": "ICLR or CRL: Which Is the Better Value Stock Right Now?",
    "published": 1712936412,
    "posting_price": 244.07000732,
    "close_price": 241.33999634,
    "percent_change": -1.11853603
  },
  {
    "title": "Charles River (CRL) Forges Collaboration With Ship of Theseus",
    "published": 1712841000,
    "posting_price": 249.30000305,
    "close_price": 246.41999817,
    "percent_change": -1.1552366
  },
  {
    "title": "Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology",
    "published": 1712836800,
    "posting_price": 249.30000305,
    "close_price": 246.41999817,
    "percent_change": -1.1552366
  },
  {
    "title": "Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics",
    "published": 1712664000,
    "posting_price": 257.27999878,
    "close_price": 257.1499939,
    "percent_change": -0.0505305
  },
  {
    "title": "Charles River, Axovia to collaborate on gene therapy development",
    "published": 1712656200,
    "posting_price": 257.27999878,
    "close_price": 257.1499939,
    "percent_change": -0.0505305
  },
  {
    "title": "Charles River announces rare disease gene therapy collaboration with Axovia",
    "published": 1712646120,
    "posting_price": 257.27999878,
    "close_price": 257.1499939,
    "percent_change": -0.0505305
  },
  {
    "title": "Charles River to Perform Plasmid Production for Ship of Theseus",
    "published": 1712232000,
    "posting_price": 261.95001221,
    "close_price": 250.66000366,
    "percent_change": -4.30998588
  },
  {
    "title": "Charles River Laboratories International, Inc.'s (NYSE:CRL) Stock Is Going Strong: Is the Market Following Fundamentals?",
    "published": 1711983451,
    "posting_price": 271.11999512,
    "close_price": 268.73001099,
    "percent_change": -0.88152264
  },
  {
    "title": "These are the most neglected stocks within each sector - BofA",
    "published": 1711975560,
    "posting_price": 271.11999512,
    "close_price": 268.73001099,
    "percent_change": -0.88152264
  },
  {
    "title": "Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024",
    "published": 1711972800,
    "posting_price": 271.11999512,
    "close_price": 268.73001099,
    "percent_change": -0.88152264
  }
]